Biofrontera Inc. Share Price

Biofrontera Inc. Share Price

NASDAQ: BFRI | Micro Cap
$0.92
+$0.04 (4.96%) Last updated on 29 Oct, 2026 | 20:10 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Biofrontera Inc. Stock Performance

Open
$0.92
Prev. Close
$0.87
Circuit Range
N/A
Day Range
$0.92 - $0.92
Year Range
$0.57 - $1.66
Volume
212
Average Traded
$0.92

Biofrontera Inc. Share Price Today

As of 30 October 2026, Biofrontera Inc.'s share price is $0.92. The stock opened at $0.92, compared to its previous close of $0.87. During today's trading session, Biofrontera Inc.'s share price traded between $0.92 and $0.92, with an average price of $0.92. Over the past 52 weeks, the stock has recorded a high of $1.66 and a low of $0.57. In terms of performance, Biofrontera Inc.'s share price has declined by 15.58% over the last six months and is down 14.79% on a year-on-year basis.

Biofrontera Inc. Share Price Chart

Line chart of the Biofrontera Inc. price trend over the selected period. The price rose overall, ranging from 0.90 to 0.92, ending at 0.92.
$0.92$0.92
L
Show Current Price
H

Biofrontera Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.32M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.43
Revenue (TTM)
$41.71B
Return On Equity (TTM)
-106.87%
Profit Margin
-25.27%
Debt to Equity
0.78
Quarterly Earnings Growth YoY
90.98%

Biofrontera Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$6.99$17.10$10.08$12.00
Net Profit-$6.65$5.64-$4.75-$0.60
Net Profit Margin-95.14%32.98%-47.12%-5.00%
Income ChangeN/A184.81%-184.22%87.37%

Biofrontera Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$28.67$34.07$37.32$41.71
Net Profit-$0.64-$20.13-$17.76-$10.54
Net Profit Margin-2.23%-59.08%-47.59%-25.27%
Income ChangeN/A-3045.31%11.77%40.65%

About Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Biofrontera Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.03
$0.92
-16.06%
Sep 2026
$1.51
$1.09
-27.09%
Aug 2026
$1.17
$1.50
+28.33%
Jul 2026
$1.01
$1.17
+22.50%
Jun 2026
$0.88
$0.95
+14.58%
May 2026
$1.07
$0.83
-23.50%
Apr 2026
$0.81
$1.08
+35.62%
Mar 2026
$0.89
$0.80
-12.28%
Feb 2026
$0.89
$0.91
-1.94%
Jan 2026
$0.59
$0.93
+55.00%
Dec 2025
$0.83
$0.60
-25.00%
Nov 2025
$1.12
$0.80
-25.58%

BFRI Share Price FAQs